Chip design software company Synopsys has offered remedies to address EU antitrust concerns regarding its $35 billion cash-and-stock acquisition of engineering software maker Ansys. The proposed remedies were filed with the European Commission on Tuesday, indicating a proactive step to secure regulatory clearance for the significant merger. This move follows an ongoing review by EU antitrust regulators.
Sources with direct knowledge of the matter indicated that Synopsys offered to sell an Ansys unit, specifically the PowerArtist RTL business, in addition to one of its own assets. Such divestitures are common strategies employed by companies to alleviate competition concerns raised by regulatory bodies. The aim is to ensure that the combined entity does not unduly dominate specific market segments.
The European Commission will now evaluate these proposed remedies to determine if they sufficiently resolve the antitrust issues identified. A positive outcome from this review would remove a major regulatory hurdle for the acquisition, which is anticipated to close in the first half of 2025. The progress in addressing EU concerns provides a clearer path forward for the merger.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.